ARWR insider trading — Arrowhead Pharmaceuticals, Inc.
Over the last 90 days, insiders at Arrowhead Pharmaceuticals, Inc. (ARWR) made 0 open-market purchases worth $0 and 2 open-market sales worth $1.19M, making them net sellers by $1.19M. The largest sale was by Perry Michael S (Director), who sold 11,600 shares for $1.01M on Aug 18, 2026.
Updated Oct 16, 2026.
Recent ARWR insider transactions
Every Form 4 filed by Arrowhead Pharmaceuticals, Inc. officers, directors and 10% owners in the last 90 days, newest first. P = open-market purchase, S = open-market sale; other codes are awards, option exercises, tax withholding or gifts.
| Trade date | Insider | Role | Type | Ownership | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| Aug 18, 2026 | Olukotun Adeoye Y | Director | S · Sale | Direct | 2,000 | $86.96 | $174K | Form 4 |
| Aug 18, 2026 | Perry Michael S | Director | S · Sale | Direct | 11,600 | $87.30 | $1.01M | Form 4 |
ARWR insider trading FAQ
Are insiders buying ARWR stock?
Not on the open market. In the last 90 days, Arrowhead Pharmaceuticals, Inc. insiders made no open-market purchases, and 2 open-market sales totaling $1.19M. Purchases with the insider's own money are generally seen as a stronger signal than sales, which happen for many reasons (taxes, diversification, planned 10b5-1 sales).
Who are the insiders trading ARWR?
Recent sellers: Olukotun Adeoye Y, Perry Michael S.
Where does ARWR insider trading data come from?
Every transaction comes from SEC Form 4 filings on EDGAR. Company officers, directors and 10% owners must file a Form 4 within two business days of buying or selling. InsiderBolt reads these filings directly from the SEC.
More stocks with insider activity
Insider trading data is for informational purposes only and is not investment advice. Filings can be amended; always confirm details on SEC EDGAR.